 | Tango Therapeutics, Inc. | |||
| NGM : TNGX || Location: United States | ||||
$7.51+0.05 (+0.67%) |
0.12 M | 7.31 - 7.6 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 10.192 M |
| March 15, 2024 | 8.885 M |
| Feb. 29, 2024 | 8.867 M |
| Feb. 15, 2024 | 9.581 M |
| Jan. 31, 2024 | 10.505 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.28 | -0.32 | -12.95% |
| 09/30/2023 | -0.35 | -0.23 | 34.64% |
| 06/30/2023 | -0.34 | -0.23 | 32.89% |
| 03/31/2023 | -0.36 | -0.32 | 10.71% |
| 12/31/2022 | -0.36 | -0.33 | 8.87% |
TNGX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 106.718M | Shares Float | 46.246M |
| Short Float | 10.192M | Market Cap | 796.12M |
| Institution ownership | 88.51% | Insider ownership | 13.512% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.08 | Forward EPS | -1.39 |